• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.13% Nasdaq Down0.30%

    Albany Molecular Research Inc. (AMRI)

    17.51 Up 0.09(0.52%) 1:24PM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Albany Molecular Research Inc.
    26 Corporate Circle
    Albany, NY 12203
    United States - Map
    Phone: 518-512-2000
    Fax: 518-512-2020
    Website: http://www.amriglobal.com

    Index Membership:N/A
    Full Time Employees:1,668

    Business Summary 

    Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. It operates through three segments: Discovery and Development Services (DDS), API, and Drug Product. The DDS segment offers services from target identification tools to investigational new drug enabling activities, such as diverse chemistry library design and synthesis, medicinal chemistry, biology, and pharmacology, including drug metabolism and pharmacokinetics. It also provides analytical chemistry services for drug discovery, and pharmaceutical development and manufacturing; and chemical development technologies to promote the solutions for route development from late lead optimization to commercial manufacturing. The API segment offers chemical synthesis and manufacturing services in accordance with current good manufacturing practices (cGMP) regulations. The Drug Product segment provides integrated pharmaceutical drug development programs and services, including process research and development, pre-formulation and formulation development, and GLP bioanalytical and separation sciences. It also offers formulation development services for solid dosage, solution, suspension, topicals, and injectables; cGMP early clinical phase capsules filling and cGMP early clinical powder in bottle for solution and suspension. In addition, this segment provides cGMP contract manufacturing services in sterile syringe and vial filling using specialized technologies, including lyophilization. The company serves pharmaceutical and biotechnology companies; government research entities and non-profit organizations; and agriculture, fine chemicals, contract chemical manufacturing, medical devices, and flavoring and cosmetics businesses. Albany Molecular Research, Inc. was founded in 1991 and is based in Albany, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Albany Molecular Research Inc.

    Corporate Governance 
    Albany Molecular Research Inc.’s ISS Governance QuickScore as of Oct 1, 2015 is 8. The pillar scores are Audit: 2; Board: 8; Shareholder Rights: 8; Compensation: 7.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Thomas E. D'Ambra Ph.D., 59
    Co-Founder and Non-Exec. Chairman
    Mr. William S. Marth , 60
    Chief Exec. Officer, Pres and Director
    Mr. George Svokos , 57
    Chief Operating Officer
    Ms. Lori M. Henderson Esq., 53
    Head of Corp. Bus. Devel., Sr. VP, Gen. Counsel and Sec.
    Dr. Steven R. Hagen Ph.D., 54
    Sr. VP of Manufacturing and Pharmaceuticals and Operations
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders